Across TCGA pan-cancer cohorts, MAPK8IP1P1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MAPK8IP1P1 data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher MAPK8IP1P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MAPK8IP1P1 expression acts as an unfavorable survival marker, although some lineages such as CESC and HNSC show a favorable association.
KICH, ACC, and CESC are the cancer types where MAPK8IP1P1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.